EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review

BACKGROUND: Limited effectiveness of therapeutic agents targeting epidermal growth factor receptor (EGFR) in clinical trials using unselected ovarian cancer patients has prompted efforts to more effectively stratify patients who might best benefit from these therapies. A series of studies that have...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehner, Christine, Oberg, Ann L., Goergen, Krista M., Kalli, Kimberly R., Maurer, Matthew J., Nassar, Aziza, Goode, Ellen L., Keeney, Gary L., Jatoi, Aminah, Radisky, Derek C., Radisky, Evette S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511892/
https://www.ncbi.nlm.nih.gov/pubmed/28740577
http://dx.doi.org/10.18632/genesandcancer.142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511892/
https://www.ncbi.nlm.nih.gov/pubmed/28740577
http://dx.doi.org/10.18632/genesandcancer.142

Ejemplares similares